Frontlight ResearchEarly access
Trial site
424 Military General Training Hospital
- 5running trials
- 6closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes3 trials
- Asthma2 trials
- Lupus (SLE)2 trials
- Obesity2 trials
- Chronic kidney disease1 trial
- COPD1 trial
- Coronary artery disease1 trial
- Eosinophilic oesophagitis1 trial
- Heart failure1 trial
- Peripheral artery disease1 trial
- Psoriasis1 trial
- Psoriatic arthritis1 trial
- and 1 more
- Phase
- Phase 38 trials
- Phase 22 trials
- Phase 41 trial
- Status
- Completed6 trials
- Active, not recruiting4 trials
- Recruiting1 trial
- Lead sponsor
- AstraZeneca3 trials
- Eli Lilly and Company2 trials
- Viatris Innovation GmbH2 trials
- AbbVie1 trial
- Hellenic Institute for the Study of Sepsis1 trial
- and 2 more
Running trials
Enrolling by invitation
Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus
Active, not recruiting
Active, not recruiting
Active, not recruiting
Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lupus (SLE)1 recruiting
Closed trials
Completed
Completed
Completed
A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Completed
Completed
Active, not recruiting
Site data: ClinicalTrials.govUpdated 18 Nov 2026